Erste Asset Management Gmb H Harmony Biosciences Holdings, Inc. Transaction History
Erste Asset Management Gmb H
- $8.15 Trillion
- Q4 2024
A detailed history of Erste Asset Management Gmb H transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Erste Asset Management Gmb H holds 13,100 shares of HRMY stock, worth $484,307. This represents 0.01% of its overall portfolio holdings.
Number of Shares
13,100
Previous 13,100
-0.0%
Holding current value
$484,307
Previous $513 Million
12.6%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding HRMY
# of Institutions
254Shares Held
46.6MCall Options Held
119KPut Options Held
50K-
Valor Management LLC Chicago, IL6.62MShares$245 Million92.04% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$216 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$175 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.28MShares$84.3 Million0.19% of portfolio
-
State Street Corp Boston, MA1.58MShares$58.4 Million0.0% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.19B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...